We use cookies, including third-party cookies from Google to serve personalized ads through AdSense, to operate this site and understand how it is used. By continuing to browse, you accept this use. See our Privacy Policy and Terms of Use for details, including how to opt out of personalized advertising.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: U.S. Pharma Industry Evolution
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Business > U.S. Pharma Industry Evolution
Business

U.S. Pharma Industry Evolution

David Avitabile
David Avitabile
Share
2 Min Read
SHARE

Injectibles

Injectibles

Last week’s news about Pfizer’s $17 billion deal to acquire Hospira, a leading generic injectibles and biosimilars company, shows some of the tectonic shifts taking place in the U.S. pharmaceutical industry. This is a big deal for a number of reasons. It demonstrates where some of the biggest growth opportunities are for pharmaceutical companies; hospital products, injectibles and biosimilars, which are generic copies of biological therapies. With an estimated $100 billion in biotech drugs losing patent protection in the next five to ten years, biosimilars represent a huge opportunity for pharma.

Perhaps the biggest signal of the changes taking place in the U.S. pharmaceutical industry is the fact that some industry analysts see Pfizer’s acquisition of Hospira as another step toward the company’s plan to split into separate businesses. Pfizer’s CEO, Ian Read, has talked about splitting the company into three separate units, one focusing on older medicines and generics, and two others focusing on developing innovative treatments. Analysts are speculating that Pfizer adding Hospira to the company’s generics business will give that unit the strength it needs to be a stand alone business.

More Read

Healthcare’s 2016 marketing trends to watch
Feds Bust Doctor for Medicare Fraud– Biggest MD Fraud Case in History
Is Your Hospital Brave Enough to Publish Online Physician Reviews?
There’s No Business Like the Healthcare Business
Largest One-YearJump in Health Spending

We’ve talked before about the need for the pharmaceutical industry to find a new strategy in the face of increasing pressures brought about by the changing U.S. healthcare system. Pfizer has become the world’s largest global pharmaceutical company through a series of major acquisitions. If pharma industry analysts are right, and Pfizer is in fact preparing itself to be split up, we are at the beginning of a total change in direction from the pharmaceutical industry’s standard business model over the past 20 years. 

 

TAGGED:pharma
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5KFollowersLike
4.5KFollowersFollow
2.8KFollowersPin
136KSubscribersSubscribe

Latest News

The Nervous System Reset Guide: Simple Ways To Manage Stress -- AI-generated illustration
The Nervous System Reset Guide: Simple Ways To Manage Stress
Infographics Mental Health
November 14, 2026
Flat editorial illustration: A single digital quality-management platform connects document control, electronic approval, audit r
6 Best QMS Software Platforms for ISO 13485 and FDA Part 820 (QMSR)
Global Healthcare Policy & Law
November 12, 2026
Flat editorial illustration: Healthcare editorial illustration about accurate patient intake connecting registration, clinical re
The Role of Patient Data Accuracy in Healthcare Operations
Global Healthcare Policy & Law
November 11, 2026
Flat editorial illustration: Healthcare ethics-and-law training, shown through a coached clinical role-play where structured disc
Medical Ethics and the Law: The Training Behind Professionals Who Resolve Healthcare Disputes
Uncategorized
November 6, 2026

You Might also Like

More From the Nursing Shortage Myth Annals

December 6, 2013
BusinessNewsPublic Health

TDI-132 Shows Promising Results in the Treatment of ALS

March 4, 2012

Long-Term Care [INFOGRAPHIC]

July 8, 2014
orthopedics
Hospital AdministrationOrthopaedicsSpecialtiesTechnology

5 Bits of Actionable Info from AAOS 2014 for Your Ortho Department

March 28, 2014
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2026 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?